Mapping a cardiomyopathy locus to chromosome 3p22-p25
- PMID: 8567977
- PMCID: PMC507047
- DOI: 10.1172/JCI118445
Mapping a cardiomyopathy locus to chromosome 3p22-p25
Abstract
Dilated cardiomyopathy (DCM) is a common disorder characterized by cardiac dilation and reduced systolic function. To identify a cardiomyopathy gene, we studied a family with DCM associated with sinus node dysfunction, supraventricular tachyarrhythmias, conduction delay, and stroke. A general linkage approach was used to localize the disease gene in this family. Linkage to D3S2303 was identified with a two-point lod score of 6.09 at a recombination fraction of 0.00. Haplotype analyses mapped this locus to a 30 cM region of chromosome 3p22-p25, excluding candidate genes encoding a G-protein (GNAI2), calcium channel (CACNL1A2), sodium channel (SCN5A), and inositol triphosphate receptor (ITPR1). These data indicate that a gene causing DCM associated with rhythm and conduction abnormalities is located on chromosome 3p, and represent the first step toward disease gene identification.
Similar articles
-
SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.Circulation. 2004 Oct 12;110(15):2163-7. doi: 10.1161/01.CIR.0000144458.58660.BB. Epub 2004 Oct 4. Circulation. 2004. PMID: 15466643
-
A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26.J Am Coll Cardiol. 2006 Jul 4;48(1):106-11. doi: 10.1016/j.jacc.2006.01.079. Epub 2006 Jun 21. J Am Coll Cardiol. 2006. PMID: 16814656
-
Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23.J Clin Invest. 1996 Sep 15;98(6):1355-60. doi: 10.1172/JCI118922. J Clin Invest. 1996. PMID: 8823300 Free PMC article.
-
[Genetics of dilated cardiomyopathy].Med Klin (Munich). 1998 Apr 15;93(4):210-4. doi: 10.1007/BF03044795. Med Klin (Munich). 1998. PMID: 9594529 Review. German.
-
Genetic factors in dilated cardiomyopathy.Arch Mal Coeur Vaiss. 1996 Jul;89 Spec No 2:15-20. Arch Mal Coeur Vaiss. 1996. PMID: 8881501 Review.
Cited by
-
Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?J Clin Invest. 2001 Jan;107(2):153-4. doi: 10.1172/JCI11998. J Clin Invest. 2001. PMID: 11160128 Free PMC article. No abstract available.
-
The genomics of cardiovascular disorders: therapeutic implications.Drugs. 2000 May;59(5):1025-42. doi: 10.2165/00003495-200059050-00001. Drugs. 2000. PMID: 10852637 Review.
-
Treating relentlessly progressive congestive heart failure: what next?Tex Heart Inst J. 1998;25(4):235-7. Tex Heart Inst J. 1998. PMID: 9885098 Free PMC article. No abstract available.
-
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.Cardiovasc Res. 2017 Jan;113(1):102-111. doi: 10.1093/cvr/cvw234. Cardiovasc Res. 2017. PMID: 28069705 Free PMC article.
-
Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families.Int J Mol Sci. 2024 Apr 25;25(9):4686. doi: 10.3390/ijms25094686. Int J Mol Sci. 2024. PMID: 38731905 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous